Abstract
Neurological complications of sarcoidosis include not only granulomatous disease but also nongranulomatous disorders such as small-fibre neuropathy (SFN) and headache. This chapter reviews the clinical manifestations of both types of disorder as well as updated diagnostic criteria, and describes newer diagnostic studies including SFN testing and details regarding current treatment options. In the last few years, there have been several reports demonstrating the beneficial effects of infliximab in treating neurosarcoidosis. Similarly, intravenous immunoglobulins may be helpful with sarcoidosis-associated SFN.
| Original language | English |
|---|---|
| Pages (from-to) | 160-173 |
| Number of pages | 14 |
| Journal | ERS Monograph |
| Volume | 2022 |
| Issue number | 96 |
| DOIs | |
| Publication status | Published - 2022 |